UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047367
Receipt number R000054025
Scientific Title Cyber knife as a treatment for malignant tumors: prospective observational study
Date of disclosure of the study information 2022/05/01
Last modified on 2022/04/02 10:00:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cyber knife as a treatment for malignant tumors: prospective observational study

Acronym

CK study

Scientific Title

Cyber knife as a treatment for malignant tumors: prospective observational study

Scientific Title:Acronym

CK study

Region

Japan


Condition

Condition

lung cancer, hepatoma, renal cancer, spinal cord tumor, and metastasis

Classification by specialty

Medicine in general Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the efficacy of cyber knife for malignant tumor.

Basic objectives2

Others

Basic objectives -Others

Local control rate.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Over all survival

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

5 fraction 35 to 45 Gy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Diameter equal to 5 cm or less than 5cm, primary lung cancer, renal cancer or hepatoma, tumor numbers equal to 3 or less than 3 metastatic lung tumor or liver tumor. Local prostate cancer or pancreas cancer. Metastasis equal to 5 or less than 5. No organs failure. Informed consent.

Key exclusion criteria

Sever organs failure. Presence of dementia.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Ohki

Organization

Shioda Memorial Hospital

Division name

Cyber knife center

Zip code

297-0203

Address

kori 550-1 Nagaramachi Choseigun Chiba

TEL

0475-35-0099

Email

anb72547@nifty.com


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Ohki

Organization

Shioda Memorial Hospital

Division name

Cyber knife center

Zip code

297-0203

Address

kori 550-1 Nagaramachi Choseigun Chiba

TEL

0475-35-0099

Homepage URL


Email

anb72547@nifty.com


Sponsor or person

Institute

Shioda Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Shioda Memorial Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shioda Memorial Hospital

Address

kori 550-1 Nagaramachi Choseigun Chiba

Tel

0475-35-0099

Email

anb72547@nifty.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2022 Year 05 Month 01 Day

Last follow-up date

2032 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 02 Day

Last modified on

2022 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054025


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name